Resources

USAID's Act | West Program Snapshot

Act to End NTDs | West Program Snapshot

This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.
Model overview

Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
2020 MDA in Togo Supported by USAID's Act to End NTDs | West Program

Gender Study Phase Two: Qualitative Gender Analysis and Gender Strategy

The gender strategy contains an actionable set of recommendations, based on literature and quantitative and qualitative data, intended to contribute to the overall achievement of Act to End NTDs | West program objectives as well as increased gender equality throughout program implementation.
Colleagues at USAID's LF TAS Workshop

Lymphatic Filariasis Operational Research Updates from NTDSC

Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.
The Carter Center's Emily Griswold

Improving Mass Drug Administration Tools

The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.
RTI's Clara Burgert and Diana Lu

High Quality Disease-Specific Assessment Implementation and Electronic Data Collection

RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.
RTI's Clara Burgert

Investigating and Responding to LF Survey Failures

RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.
Abdel Direny, IMA Worldhealth

Transmission Assessment Survey Preparation and Supervision

IMA World Health's Abdel Direny, MD, MPH, presented guidance for transmission assessment survey preparation and supervision on January 15, 2020.
Emily Toubali, USAID

USAID NTD Division - Overview of Lymphatic Filariasis

USAID's Emily Toubali provided an overview of the NTD Division's work on lymphatic filariasis on January 14, 2020
Conference attendees learn how to use the WHO LF diagnostics feedback form

WHO Lymphatic Filariasis Diagnostic Feedback Form (English)

WHO form to provide feedback on invalid lymphatic filariasis diagnostic tests (English version).